The company closed its plan on September 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.13 CNY | -1.57% | -4.91% | -13.14% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.14% | 1.34B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 22, 2022, has closed with 18,489,100 shares, representing 1.55% for CNY 194.73 million.